Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, February 18, 2019

Vaccination, antiviral treatment fails to affect stroke risk from herpes zoster(Shingles)

You'll have to ask your doctor what this means and whether you should get the more advanced vaccine from 2017. 

Vaccination, antiviral treatment fails to affect stroke risk from herpes zoster(Shingles)

Contracting herpes zoster increased risk for acute ischemic stroke, and among patients with herpes zoster, vaccination or antiviral treatment did not modify the risk, according to data presented at the International Stroke Conference.
Previous studies had shown that herpes zoster increases risk for acute ischemic stroke, but none had evaluated the effect of vaccination or antiviral treatment after herpes zoster infection on stroke risk, Quanhe Yang, PhD, senior scientist with the epidemiology and surveillance branch in the CDC’s Division for Heart Disease and Stroke Prevention, and colleagues wrote in an abstract.
The researchers analyzed 35,186 Medicare fee-for-service beneficiaries who were diagnosed with herpes zoster and acute ischemic stroke between 2007 and 2015.
Participants were stratified into four groups: those with no vaccination or antiviral treatment (49%), those with vaccination but no antiviral treatment (9%), those with antiviral treatment but no vaccination (34%) and those with both vaccination and antiviral treatment (8%).
Incident rate ratios for acute ischemic stroke were 1.61 (95% CI, 1.51-1.7) at 0 to 14 days, 1.35 (95% CI, 1.27-1.44) at 15 to 30 days, 1.16 (95% CI, 1.12-1.2) at 31 to 90 days, and 1.05 (95% CI, 1.02-1.08) at 91 to 180 days, according to the researchers.
Yang and colleagues found no effect modification due to vaccination or antiviral treatment (P for interaction = .6) after onset of herpes zoster. They also found the results were consistent regardless of race/ethnicity and sex.
“Risk of [acute ischemic stroke] increased significantly following [herpes zoster], and this increased risk didn’t appear to be modified by [herpes zoster] vaccination and antiviral treatment following [herpes zoster],” Yang and colleagues wrote in the abstract. “Primary prevention of [herpes zoster] by [herpes zoster] vaccination might be the most effective approach to prevent [herpes zoster]-associated [acute ischemic stroke].” – by Erik Swain
Reference:
Yang Q, et al. Abstract 39. Presented at: International Stroke Conference; Feb. 5-8, 2019; Honolulu.
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)